Placebo dose

DRUG2 trials

Sponsors

Procter and Gamble, Sun Pharmaceutical Industries Limited

Conditions

Active Ankylosing Spondylitis or Non-Radiographic Axial SpondyloarthritisRheumatoid Arthritis

Phase 2

Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate

CompletedNCT00369928

Procter and GambleRheumatoid Arthritis

Start: 2006-08-31End: 2008-01-31Updated: 2011-09-08

Efficacy and Safety Study of SUNPG1622

TerminatedNCT02980705

Sun Pharmaceutical Industries LimitedActive Ankylosing Spondylitis or Non-Radiographic Axial Spondyloarthritis

Start: 2017-11-06End: 2019-09-03Updated: 2021-11-01

Related Papers

A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis

JCR Journal of Clinical Rheumatology2023-05-103 citations